Search

Your search keyword '"Sunny H Wong"' showing total 327 results

Search Constraints

Start Over You searched for: Author "Sunny H Wong" Remove constraint Author: "Sunny H Wong"
327 results on '"Sunny H Wong"'

Search Results

1. Association between alcohol flushing syndrome and cancer: A systematic review and meta-analysis

2. Outcomes of respiratory viral-bacterial co-infection in adult hospitalized patients

Catalog

Books, media, physical & digital resources

3. Association between well-being and compliance with COVID-19 preventive measures by healthcare professionals: A cross-sectional study.

4. Serrated neoplasia in the colorectum: gut microbiota and molecular pathways

5. Systematic review of human gut resistome studies revealed variable definitions and approaches

6. Leprosy and the adaptation of human toll-like receptor 1.

7. Development of an Open‐Access and Explainable Machine Learning Prediction System to Assess the Mortality and Recurrence Risk Factors of Clostridioides Difficile Infection Patients

10. Disease Burden of Clostridium difficile Infections in Adults, Hong Kong, China, 2006–2014

12. Changing epidemiological trends of inflammatory bowel disease in Asia

13. Supplementary Table 1 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

14. Supplementary Video S4 from MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer

15. Supplementary Figure 1 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

16. Supplementary Dataset 2 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

17. Supplementary Dataset 3 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

18. Supplementary Data from MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer

19. Supplementary Dataset 1 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

20. Supplementary Figure 3 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

21. Data from MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer

22. Supplementary Table S6 from MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer

23. Supplementary Figure 2 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

24. Supplementary Figure S5 from Epigenetic Silencing of miR-490-3p Reactivates the Chromatin Remodeler SMARCD1 to Promote Helicobacter pylori–Induced Gastric Carcinogenesis

25. Supplementary Table S1 from Epigenetic Silencing of miR-490-3p Reactivates the Chromatin Remodeler SMARCD1 to Promote Helicobacter pylori–Induced Gastric Carcinogenesis

26. Data from Epigenetic Silencing of miR-490-3p Reactivates the Chromatin Remodeler SMARCD1 to Promote Helicobacter pylori–Induced Gastric Carcinogenesis

27. Supplementary Materials and Methods and Figure Legends from Epigenetic Silencing of miR-490-3p Reactivates the Chromatin Remodeler SMARCD1 to Promote Helicobacter pylori–Induced Gastric Carcinogenesis

28. Supplementary Figure Legends from Epigenetic Silencing of miR-490-3p Reactivates the Chromatin Remodeler SMARCD1 to Promote Helicobacter pylori–Induced Gastric Carcinogenesis

30. Plasminogen Activator Inhibitor 1 for Predicting Sepsis Severity and Mortality Outcomes: A Systematic Review and Meta-Analysis

31. Atrial Fibrillation Recurrence and Peri-Procedural Complication Rates in nMARQ vs. Conventional Ablation Techniques: A Systematic Review and Meta-Analysis

32. Understanding the gut microbiota and sarcopenia: a systematic review

33. Intake of processed meat, but not sodium, is associated with risk of colorectal cancer: Evidence from a large prospective cohort and two-sample Mendelian randomization

34. An elevated anxiety level among prepubertal autistic boys with non‐treatment‐seeking functional gastrointestinal disorders: A case–control study

35. A cross-sectional study on gut microbiota in prostate cancer patients with prostatectomy or androgen deprivation therapy

36. Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis

37. Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong

38. The potential impact of previous exposure to SARS or MERS on control of the COVID-19 pandemic

39. Coronavirus Disease 2019 (COVID-19): A Haematologist’s Perspective

40. Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer

41. Exploring the Pathogenesis, Clinical Characteristics and Therapeutic Regimens of Listeria monocytogenes

42. MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer

43. Regional differences in temporal incidence of Clostridium difficile infection: a systematic review and meta-analysis

44. Stress Hyperglycemia Is Associated With an Increased Risk of Subsequent Development of Diabetes Among Bacteremic and Nonbacteremic Patients

45. Artificial Intelligence-Assisted Colonoscopy for Colorectal Cancer Screening: A Multicenter Randomized Controlled Trial

46. Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis

47. Gut Microbiota Across Early Stages of Alpha-Synucleinopathy: From High-Risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's Disease

48. What is unknown in using microbiota as a therapeutic?

49. Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities

50. An update on the roles of circular RNAs in spinal cord injury